Priyadarshini Balasubramanian, MD
Assistant Professor of Medicine (Endocrinology)
Research & Publications
Biography
News
Coauthors
Selected Publications
- Multidisciplinary strategies to treat severe hypoglycemia in hospitalized patients with diabetes mellitus reduce inpatient mortality rate: Experience from an academic community hospitalKadayakkara D, Balasubramanian P, Araque K, Davis K, Javed F, Niaki P, Majumdar S, Buller G. Multidisciplinary strategies to treat severe hypoglycemia in hospitalized patients with diabetes mellitus reduce inpatient mortality rate: Experience from an academic community hospital. PLOS ONE 2019, 14: e0220956. PMID: 31393971, PMCID: PMC6687156, DOI: 10.1371/journal.pone.0220956.
- A Case of Pseudohypoparathyroidism Type 1b in PregnancyBalasubramanian P, Lupsa B. A Case of Pseudohypoparathyroidism Type 1b in Pregnancy. Journal Of The Endocrine Society 2021, 5: a172-a172. PMCID: PMC8089272, DOI: 10.1210/jendso/bvab048.347.
- Baseline Cardiovascular Risk Factor Control in Patients With Type 2 Diabetes and Coronary Disease Versus Stroke: Secondary Analysis of Cardiovascular Outcome TrialsBalasubramanian P, Kernan W, Sheth K, Ofstad A, Rosenstock J, Wanner C, Zinman B, Mattheus M, Marx N, Inzucchi S. Baseline Cardiovascular Risk Factor Control in Patients With Type 2 Diabetes and Coronary Disease Versus Stroke: Secondary Analysis of Cardiovascular Outcome Trials. Stroke 2023, 54: 2013-2021. PMID: 37449424, PMCID: PMC10358436, DOI: 10.1161/strokeaha.122.042053.
- Chapter 13 Sodium-glucose Co-transporter-2 inhibitors: a new era of cardioprotection and renoprotectionBalasubramanian P, Inzucchi S. Chapter 13 Sodium-glucose Co-transporter-2 inhibitors: a new era of cardioprotection and renoprotection. 2023, 337-363. DOI: 10.1016/b978-0-323-99991-5.00006-1.
- Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition?Balasubramanian P, Wanner C, Ferreira J, Ofstad A, Elsaesser A, Zinman B, Inzucchi S. Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition? Medicine Of Ukraine 2022, 48-52. DOI: 10.37987/1997-9894.2022.5-6(261-2).271666.
- Calcitriol mediated hypercalcemia due to necrotizing sarcoid granuloma of the liverBalasubramanian P, Kadayakkara DK, Soloway G, Laskin W, Majumdar S. Calcitriol mediated hypercalcemia due to necrotizing sarcoid granuloma of the liver. Int J Case Rep Images 2017;8(7):458–461.
- Extreme High Insulin Requirements in Two Non-Diabetic Patients Following Cardiac TransplantationBalasubramanian P, Moreau C, Ahmad T, Inzucchi S. Extreme High Insulin Requirements in Two Non-Diabetic Patients Following Cardiac Transplantation. Journal Of The Endocrine Society 2021, 5: a383-a383. PMCID: PMC8090379, DOI: 10.1210/jendso/bvab048.780.
- Albumin-Corrected Calcium and the Prevalence and Categories of Hypercalcemia in Hospitalized Patients With 1-Year Follow-Up of Undiagnosed CasesBalasubramanian.P, S. K. Majumdar, Albumin-Corrected Calcium and the Prevalence and Categories of Hypercalcemia in Hospitalized Patients With 1-Year Follow-Up of Undiagnosed Cases, Endocrine Practice, Volume 27, Issue 4, 2021, Pages 279-285.